Assessing Response in Atopic Dermatitis: A Systematic Review of the Psychometric Performance of Measures Used in HTAs and Clinical Trials.
Hannah PentonSayeli JayadeSanthani SelveindranMarieke HeisenChristophe PikettyLiliana UlianovZarif K Jabbar-LopezJonathan I SilverbergJorge PuellesPublished in: Dermatology and therapy (2023)
Content validation of the PP-NRS confirmed the importance of itch as a core symptom and treatment priority in AD; however, itch is not well covered in the EASI or IGA. Including the PP-NRS in clinical trials and HTAs will better capture patient-relevant benefit and response. Although various response criteria were used, no studies compared the performance of different criteria to inform which were most appropriate to compare treatments in clinical trials and HTAs.